Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 2Phase 1 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1

Conditions

Central Nervous System Neoplasms 12Astrocytoma 10Brain Neoplasms 9Lymphoma, Non-Hodgkin 8Gliosarcoma 8Glioblastoma 8Oligodendroglioma 7Lymphoma, Large B-Cell, Diffuse 7Lymphoma 7Glioma 7Lymphoma, Mantle-Cell 6Lymphoma, Follicular 5Burkitt Lymphoma 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Large-Cell, Immunoblastic 4Leukemia, Lymphocytic, Chronic, B-Cell 4Ependymoma 4Recurrence 3Lymphoma, T-Cell, Cutaneous 3Lymphoma, B-Cell, Marginal Zone 3Hodgkin Disease 3Neuroectodermal Tumors, Primitive 2Multiple Myeloma 2Medulloblastoma 2Lymphoma, B-Cell 2Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pediatric Brain Tumor 1

Interventions

Cyclophosphamide 38fludarabine 30Rituximab 26obinutuzumab 10Bendamustine Hydrochloride 10fludarabine phosphate 9pembrolizumab 8Specimen Handling 7Etoposide 7venetoclax 6Vincristine 6Prednisone 6Magnetic Resonance Spectroscopy 6Leukapheresis 6Lenalidomide 6ibrutinib 5Inotuzumab Ozogamicin 5Immunotherapy, Adoptive 5Doxorubicin 5Biopsy 5ublituximab 4tazemetostat 4glofitamab 4Interleukin-2 4Dexamethasone 4Cytarabine 4pomalidomide 3polatuzumab vedotin 3Radiation 3Nivolumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Lymphoma, B-Cell × Carmustine × Clear all
NCT00968760 2023-12-19

CD19-specific T Cell Infusion in Patients With B-Lineage Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
34 enrolled
LymphoidOther hematologic neoplasm

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, Mantle-Cell

NCT02483000 2020-11-23

Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies

Fred Hutchinson Cancer Center

Phase 1 Terminated
3 enrolled 12 charts
Lymphoid

Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡